Clinical Trial ECOGTHO5508-M
Title
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Principal Investigator(s)
John Murray
Details
- Protocol No. ECOGTHO5508-M
- Open Date: 02/09/2011
- Staging: Phase III
- Age Group: Adults
- Scope: National
- Objective:
- Disease Sites: Non Small Cell
- Therapies: Chemotherapy - cytotoxic; Molecular Targeted Agents / Immunotherapy / Biologics
- Drugs: None Specified
- Participating Institutions: Meharry Medical College
- Secondary Protocol No: 5508
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
